|
TSFM expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.389800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.849400E-04 |
| Normal-vs-Stage2 |
1.305420E-01 |
| Normal-vs-Stage3 |
4.44569999999977E-05 |
| Normal-vs-Stage4 |
1.12560000209427E-08 |
| Stage1-vs-Stage2 |
1.080710E-03 |
| Stage1-vs-Stage3 |
1.732620E-01 |
| Stage1-vs-Stage4 |
5.155200E-04 |
| Stage2-vs-Stage3 |
2.166600E-04 |
| Stage2-vs-Stage4 |
2.97719999997614E-06 |
| Stage3-vs-Stage4 |
6.168300E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.64010000000592E-05 |
| Normal-vs-AfricanAmerican |
8.315700E-02 |
| Normal-vs-Asian |
1.02130000012579E-08 |
| Caucasian-vs-AfricanAmerican |
4.476200E-01 |
| Caucasian-vs-Asian |
1.496550E-03 |
| AfricanAmerican-vs-Asian |
3.339800E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.371700E-04 |
| Normal-vs-Female |
7.611400E-04 |
| Male-vs-Female |
3.596600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.16540000000221E-05 |
| Normal-vs-Age(41-60Yrs) |
3.846000E-04 |
| Normal-vs-Age(61-80Yrs) |
3.111800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.095600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.426400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.069960E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.681800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.327700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.864200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.921400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.003400E-03 |
| Classical-VS-Follicular |
1.50060000003727E-06 |
| Classical-VS-Other |
9.321200E-01 |
| Classical-VS-Normal |
2.46109999999522E-05 |
| Tall-VS-Follicular |
2.5958000193782E-09 |
| Tall-VS-Other |
1.366990E-01 |
| Tall-VS-Normal |
1.08230000517295E-08 |
| Follicular-VS-Other |
1.508990E-01 |
| Follicular-VS-Normal |
2.900400E-01 |
| Other-VS-Normal |
7.531500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.496400E-02 |
| Normal-vs-N1 |
1.03219999214588E-09 |
| N0-vs-N1 |
1.18929999959327E-07 |
|
|
